Which statement about phosphate binders is true in CKD-MBD management?

• A. They help control phosphate levels and are part of CKD-MBD management
• B. They inherently raise calcium levels in all patients
• C. They replace vitamin D
• D. They have no role in bone health

Answer: (A)

Phosphate binders work by binding phosphate in the gut so that less phosphate is absorbed into the bloodstream. In CKD, the kidneys struggle to excrete phosphate, so hyperphosphatemia becomes common and drives mineral and bone disorder as well as vascular calcification. By lowering dietary phosphate absorption, binders help maintain phosphate in a healthier range, making them a central part of CKD-MBD management.

They don’t inherently raise calcium levels in all patients—some binders are calcium-based and can contribute to higher calcium in certain individuals, but this isn’t universal. They also don’t replace vitamin D; binders are used alongside vitamin D therapies when needed. And they do play a role in bone health by reducing phosphate-related effects on bone turnover and mineral balance.

So, the best statement is that phosphate binders help control phosphate levels and are part of CKD-MBD management.